Combining two unique AI platforms for the discovery of novel therapeutic targets & preclinical validation of synthetic biomolecules to treat AML

Forschungsstelle

INNOSUISSE

Projektnummer

109.188 INT-LS

Projekttitel

Combining two unique AI platforms for the discovery of novel therapeutic targets & preclinical validation of synthetic biomolecules to treat AML

Projekttitel Englisch

Combining two unique AI platforms for the discovery of novel therapeutic targets & preclinical validation of synthetic biomolecules to treat AML

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Pharmaceuticals, Deep learning, Medtech, Machine learning, Personalised medicine, Artificial/local/extended/networked intelligence
Abstract (Englisch)	AMPLY Discovery and Nexco Analytics are combining their novel AI-based drug discovery approaches to advance a unique first-in-class platform, which will identify, and triage, novel targets and discover, and validate, new biologic therapeutic candidates to treat AML.